GNRH1 and polycystic ovary syndrome: Multiple meta-analyses have compared clinical outcomes between the GnRH agonist long protocol and the GnRH antagonist protocol in PCOS patients with high ovarian reserve (AFC > 24) and found no difference in clinical pregnancy rate between the two protocols (15–17).